Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.285 SEK | -9.70% |
|
+24.55% | +12.72% |
20/06 | Transcript : Egetis Therapeutics AB - Special Call | |
19/06 | Egetis Therapeutics AB Announces Topline Results of the Phase 2 Triac Trial II with Emcitate for MCT8 Deficiency | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.72% | 193M | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.56% | 27.52B | |
-18.07% | 20.87B | |
-14.01% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- EGTX Stock
- News Egetis Therapeutics AB
- PledPharma AB Appoints Yilmaz Mahshid as Chief Financial Officer